These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Kirk CJ; Hartigan-O'Connor D; Nickoloff BJ; Chamberlain JS; Giedlin M; Aukerman L; Mule JJ Cancer Res; 2001 Mar; 61(5):2062-70. PubMed ID: 11280767 [TBL] [Abstract][Full Text] [Related]
4. Induction of potent antitumor natural killer cell activity by herpes simplex virus-thymidine kinase and ganciclovir therapy in an orthotopic mouse model of prostate cancer. Hall SJ; Sanford MA; Atkinson G; Chen SH Cancer Res; 1998 Aug; 58(15):3221-5. PubMed ID: 9699645 [TBL] [Abstract][Full Text] [Related]
5. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714 [TBL] [Abstract][Full Text] [Related]
6. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC. Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034 [TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma. Tsuchiyama T; Kaneko S; Nakamoto Y; Sakai Y; Honda M; Mukaida N; Kobayashi K Cancer Gene Ther; 2003 Apr; 10(4):260-9. PubMed ID: 12679798 [TBL] [Abstract][Full Text] [Related]
8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
9. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine. Ren W; Strube R; Zhang X; Chen SY; Huang XF Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979 [TBL] [Abstract][Full Text] [Related]
10. Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells. Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL Cancer Gene Ther; 1999; 6(4):358-66. PubMed ID: 10419054 [TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of murine liver cancer with IL-12 gene and HSV-TK gene]. Tang Z; Sun W; Chen S Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):332-5. PubMed ID: 11776567 [TBL] [Abstract][Full Text] [Related]
12. [Experimental studies on the characteristics of suicide gene system HSV-tk/GCV and its effect on dendritic cells]. Wang X; Li L; Feng K; Bai L; Pei X Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):628-31. PubMed ID: 11877036 [TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells. Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292 [TBL] [Abstract][Full Text] [Related]
14. Combinatory gene therapy with electrotransfer of midkine promoter-HSV-TK and interleukin-21. Hanari N; Matsubara H; Hoshino I; Akutsu Y; Nishimori T; Murakami K; Sakata H; Miyazawa Y; Ochiai T Anticancer Res; 2007; 27(4B):2305-10. PubMed ID: 17695518 [TBL] [Abstract][Full Text] [Related]
15. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
16. [Combined interleukin-2 and herpes simplex virus thymidine kinase gene therapy for head and neck squamous cell carcinoma]. Liu S; Liang C; Yang H; Xian J Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Dec; 36(6):426-9. PubMed ID: 12761956 [TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer. Kagaya T; Nakamoto Y; Sakai Y; Tsuchiyama T; Yagita H; Mukaida N; Kaneko S Cancer Gene Ther; 2006 Apr; 13(4):357-66. PubMed ID: 16224495 [TBL] [Abstract][Full Text] [Related]